Hardin Capital Partners’s Eli Lilly LLY Stock Holding History

Hardin Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	1,106 -158	-13%	-$161K	0.62%	27
2026 Q1	$1.16M	Sell	1,264 -1	-0.1%	-$1.01K	0.54%	33
2025 Q4	$1.36M	Buy	1,265 +133	+12%	+$127K	0.64%	23
2025 Q3	$864K	Buy	1,132 +28	+3%	+$20.8K	0.46%	40
2025 Q2	$857K	Sell	1,104 -171	-13%	-$133K	0.5%	36
2025 Q1	$1.05M	Buy	1,275 +5	+0.4%	+$4.16K	0.65%	22
2024 Q4	$980K	Sell	1,270 -19	-1%	-$15.7K	0.59%	26
2024 Q3	$1.18M	Buy	1,289 +3	+0.2%	+$2.7K	0.67%	19
2024 Q2	$1.16M	Buy	+1,286	New	+$1.03M	0.76%	18

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Hardin Capital Partners's LLY Position: Q2 2026 in Review

Hardin Capital Partners reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $161K and leaving 1,106 shares worth $1.34M. The position accounts for 0.62% of the portfolio, ranked #27.

Hardin Capital Partners first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.36M in Q4 2025. 2,854 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Hardin Capital Partners held 1,106 shares of Eli Lilly worth $1.34M as of Q2 2026.
Hardin Capital Partners sold 158 Eli Lilly shares in Q2 2026, an estimated $161K.
Eli Lilly made up 0.62% of Hardin Capital Partners's portfolio in Q2 2026, its #27 holding.
Hardin Capital Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
Hardin Capital Partners's Eli Lilly position peaked at $1.36M in Q4 2025.
2,854 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hardin Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.